Navigation Links
Cyberkinetics Requests FDA to Sell Nerve Growth Stimulation System

Cyberkinetics, Inc, winner of the Medgadget "Most Sci-Fi Sounding Company Name" Award, has asked the FDA for permission to market// their Andara OFS nerve growth stimulation system.

According to Cyberkinetics, “Cyberkinetics' Andara? OFS? System consists of a battery-powered device about the size of a cardiac pacemaker with six electrical leads. Three of the leads are attached to the vertebrae at a distance of two disk-segments above the area of injury, and three are attached to the vertebrae at a distance of two disk-segments below the injury. By applying an oscillating, low-voltage, direct current of electricity to the areas above and below a spinal cord injury, the Andara? OFS? System creates an electrical field that surrounds the injury and stimulates the nerves surrounding the spinal cord to grow and form new connections that can restore sensory and motor function. The Andara? OFS? System is an investigational device. It is not currently approved for sale and is available only through participation in a clinical study.

Cyberkinetics has filed an application for Humanitarian Use Device status from the FDA. If the application is successful, Cyberkinetics could market the device commercially in late 2007.

Basically, the new humanitarian exemption would mean that they could actually sell the device, rather than only use it through clinical trials.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Canadian Street Prostitutes Requests Protection
2. New Zealand Requests Details from Britain about ‘Black Sheep
3. Patients Requests for Antidepressants can Influence Physician Evaluation of Depression
4. FDA Requests Label Change for All Sleep Disorder Drug Products
5. Epilepsy Drug Helps Diabetic Nerve Damage
6. World’s First Nerve Stem Cells Produced
7. Children With Epilepsy Can Be Treated With Nerve Stimulation
8. FDA Approved Nerve-Stimulation Therapy Now Available In New York
9. Doctors Finish Mother-To-Son Nerve Surgery
10. Stem Cells From Hair Follicle To Repair Nerve Damage
11. Nerve regeneration for Spinal cord injuries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy ... enhancement of their 503A compounding pharmacy located in Ocala, Florida. , Meeting ... and patients throughout the United States for high-quality human anti-aging and wellness ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... Somerset, N.J. (PRWEB) , ... January 19, 2017 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Medicines with Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery ...
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, ... fillers that resulted in severe facial disfiguration. After four frightening years of isolation ... at UCLA Medical Center, who removed the substances in a partial facial transplant ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate Medical Academy (UMA) ... are passionate about making a difference in the lives of the next generation ... a nonprofit healthcare educational institution, has more than 30,000 alumni and employs more ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 19, 2017 Pfizer ... the Milner Therapeutics Consortium   Major ... Cambridge   The Milner ... PFE ) as a partner to the Milner Therapeutics ... enables the efficient transfer of materials between industry and ...
(Date:1/19/2017)... 18, 2017  ViewRay, Inc. (Nasdaq: ... only clinical MRI-guided radiation therapy system, announced today that ... $26.1 million through a private placement of its ... the financing and was joined by certain of ... Kearny Venture Partners, and an additional new institutional ...
(Date:1/19/2017)... Jan. 18, 2017 The Academy of ... Drug Administration (FDA) for its release today of ... health decision makers can proactively share clinical and ... well as emerging therapies awaiting FDA approval. ... recommendations that AMCP developed during two multi-stakeholder meetings ...
Breaking Medicine Technology: